LUCENTIS

Genentech, Inc.

Application Filed: 2003-04-16
Trademark Application Details
Trademark Logo LUCENTIS

Mark For: LUCENTIS® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of [ cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, ] angiogenesis diseases and disorders, * and * ocular diseases and disorders [ , or inflammatory diseases and disorders ]. [all]

Status

2022-07-22 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number78238446
Registration Number3169327
Mark Literal ElementsLUCENTIS
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Affidavit TextSECT 15. SECT 8 (6-YR). SECTION 8(10-YR) 20170112.
Affidavit Text1ST RENEWAL 20170112
Current LocationGENERIC WEB UPDATE 2017-01-12
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameRonald E. Shapiro
Attorney Docket NumberCPA14217
Law Office AssignedL90
Employee NameSAUNDERS, ANDREA DAWN

Timeline

1ST RENEWAL 20170112Renewal Date
2003-04-16Application Filed
2003-06-24Date of First Use
2003-12-09Published
2003-12-09Published for Opposition
2006-06-30Date of Use In Commerce
2006-11-07Trademark Registered
2016-11-07Renewal Date
2017-01-12Location: GENERIC WEB UPDATE
2017-01-12Status: Live/Registered
2017-01-12Status: The registration has been renewed.
2018-07-08Transaction Date
2025-11-07Maintenance Early File Date
2026-11-09Maintenance On Time Date
2027-05-07Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: GENENTECH, INC.
Address1 DNA WAY SOUTH SAN FRANCISCO, CALIFORNIA UNITED STATES 940804990
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Application2003-04-16
Drawing2003-04-16
XSearch Search Summary2003-09-21
Change of Address2003-11-18
Notice of Publication2003-11-19
Paper Correspondence Incoming2003-12-15
Notice of Allowance2004-02-20
Change of Address2004-07-05
Extension of Time to File SOU2004-07-28
ITU Extension Approval2004-08-18
Extension of Time to File SOU2005-02-14
Change of Address2005-02-18
ITU Extension Approval2005-03-03
Extension of Time to File SOU2005-08-29
ITU Extension Approval2005-08-31
Extension of Time to File SOU2006-02-06
Specimen2006-02-06
ITU Extension Approval2006-02-08
Extension of Time to File SOU2006-08-03
Specimen2006-08-03
Specimen2006-08-03
Statement of Use2006-08-03
ITU Extension Approval2006-09-12
Change of Address2006-09-19
TRAM Snapshot of App at Pub for Oppostn2006-09-20
Notice of Acceptance of Statement of Use2006-10-03
Registration Certificate2006-11-07
Paper Correspondence Incoming2007-10-15
PR-Updated Reg Certificates2008-05-06
Section 8 and 152012-09-05
Specimen2012-09-05
Notice of Acceptance Acknowledgement2012-09-22
Courtesy E-Reminder of Sec. 8/Sec. 92015-11-07
PR-Section 8 and 92016-11-01
Specimen2016-11-01
Notice-Acceptance-Renewal2017-01-12
Change Address or Representation Form2021-04-19
Change Address or Representation FormAPPLICATION/XML2021-08-11

Attorney of Record

Ronald E. Shapiro
Shapiro and Silverstein PLLC
11350 Random Hills Road, Suite 740
Fairfax VA 22030

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF [ CARDIOVASCULAR DISEASES AND DISORDERS, ONCOLOGICAL DISEASES AND DISORDERS, IMMUNE DISEASES AND DISORDERS, ] ANGIOGENESIS DISEASES AND DISORDERS, * AND * OCULAR DISEASES AND DISORDERS [ , OR INFLAMMATORY DISEASES AND DISORDERS ]. FIRST USE: 20030624. FIRST USE IN COMMERCE: 20060630

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
A00001In the statement, column 1, lines 6 thru 10, and column 2, lines 1 and 2, should be deleted and "Pharmaceutical preparations for the treatment of angiogenesis diseases and disorders and ocular diseases and disorders" should be inserted.

Trademark Filing History

DescriptionDateProceeding Number
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2021-08-11
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2021-08-11
TEAS CHANGE OF CORRESPONDENCE RECEIVED2021-08-11
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2021-08-11
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2021-04-19
TEAS CHANGE OF OWNER ADDRESS RECEIVED2021-04-19
TEAS CHANGE OF CORRESPONDENCE RECEIVED2021-04-19
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2021-04-19
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2021-04-1988888
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)2017-01-1276873
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED2017-01-1276873
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED2017-01-12
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2017-01-1076873
TEAS SECTION 8 & 9 RECEIVED2016-11-01
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED2015-11-07
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.2012-09-2268335
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED2012-09-22
CASE ASSIGNED TO POST REGISTRATION PARALEGAL2012-09-2268335
TEAS SECTION 8 & 15 RECEIVED2012-09-05
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED2012-09-0568335
AMENDMENT UNDER SECTION 7 – PROCESSED2008-04-03
ASSIGNED TO PARALEGAL2007-11-1970131
SEC 7 REQUEST FILED2007-10-15
PAPER RECEIVED2007-10-15
REGISTERED-PRINCIPAL REGISTER2006-11-07
LAW OFFICE REGISTRATION REVIEW COMPLETED2006-09-2878413
ASSIGNED TO LIE2006-09-2878413
TEAS CHANGE OF CORRESPONDENCE RECEIVED2006-09-19
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2006-09-19
STATEMENT OF USE PROCESSING COMPLETE2006-09-0976569
SOU EXTENSION 5 GRANTED2006-09-0976569
USE AMENDMENT FILED2006-08-0376569
TEAS STATEMENT OF USE RECEIVED2006-08-03
TEAS EXTENSION RECEIVED2006-08-03
SOU EXTENSION 5 FILED2006-08-0376569
TEAS EXTENSION RECEIVED2006-02-06
SOU EXTENSION 4 GRANTED2006-02-0698765
SOU EXTENSION 4 FILED2006-02-0698765
TEAS EXTENSION RECEIVED2005-08-29
SOU EXTENSION 3 GRANTED2005-08-2998765
SOU EXTENSION 3 FILED2005-08-2998765
SOU EXTENSION 2 GRANTED2005-03-0271427
TEAS CHANGE OF CORRESPONDENCE RECEIVED2005-02-18
TEAS EXTENSION RECEIVED2005-02-14
SOU EXTENSION 2 FILED2005-02-1471427
SOU EXTENSION 1 GRANTED2004-08-17
TEAS EXTENSION RECEIVED2004-07-28
SOU EXTENSION 1 FILED2004-07-28
TEAS CHANGE OF CORRESPONDENCE RECEIVED2004-07-05
NOA MAILED - SOU REQUIRED FROM APPLICANT2004-03-02
PAPER RECEIVED2003-12-15
PUBLISHED FOR OPPOSITION2003-12-09
NOTICE OF PUBLICATION2003-11-19
TEAS CHANGE OF CORRESPONDENCE RECEIVED2003-11-18
ASSIGNED TO EXAMINER2003-09-2176851
APPROVED FOR PUB - PRINCIPAL REGISTER2003-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed